Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.

Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA.

Cancer. 2013 Apr 1;119(7):1402-11. doi: 10.1002/cncr.27795. Epub 2013 Jan 28.

2.

Early-stage young breast cancer patients: impact of local treatment on survival.

Bantema-Joppe EJ, de Munck L, Visser O, Willemse PH, Langendijk JA, Siesling S, Maduro JH.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e553-9. doi: 10.1016/j.ijrobp.2011.02.060. Epub 2011 Sep 9.

3.

Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.

Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J.

JAMA Surg. 2014 Mar;149(3):267-74. doi: 10.1001/jamasurg.2013.3049.

PMID:
24429935
4.

Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.

Ye JC, Yan W, Christos PJ, Nori D, Ravi A.

Clin Breast Cancer. 2015 Oct;15(5):390-7. doi: 10.1016/j.clbc.2015.03.012. Epub 2015 Apr 2.

PMID:
25957740
5.

Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.

Mahmood U, Morris C, Neuner G, Koshy M, Kesmodel S, Buras R, Chumsri S, Bao T, Tkaczuk K, Feigenberg S.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1387-93. doi: 10.1016/j.ijrobp.2011.10.075. Epub 2012 Jan 31.

PMID:
22300561
6.

Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF.

Ann Surg Oncol. 2015 Nov;22(12):3836-45. doi: 10.1245/s10434-015-4441-3. Epub 2015 Mar 6.

7.

Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.

Jeon YW, Choi JE, Park HK, Kim KS, Lee JY, Suh YJ.

Breast Cancer Res Treat. 2013 Apr;138(2):475-84. doi: 10.1007/s10549-013-2456-7. Epub 2013 Mar 3.

PMID:
23456232
8.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. Epub 2005 Jul 11.

PMID:
16005576
9.

Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.

Hofvind S, Holen Å, Aas T, Roman M, Sebuødegård S, Akslen LA.

Eur J Surg Oncol. 2015 Oct;41(10):1417-22. doi: 10.1016/j.ejso.2015.07.002. Epub 2015 Jul 17.

PMID:
26253193
10.

Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.

Cao JQ, Truong PT, Olivotto IA, Olson R, Coulombe G, Keyes M, Weir L, Gelmon K, Bernstein V, Woods R, Speers C, Tyldesley S.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):509-17. doi: 10.1016/j.ijrobp.2014.06.041. Epub 2014 Sep 3.

PMID:
25194665
11.

Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy.

Vila J, Gandini S, Gentilini O.

Breast. 2015 Jun;24(3):175-81. doi: 10.1016/j.breast.2015.02.002. Epub 2015 Feb 23. Review.

PMID:
25728282
12.

Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer.

Parviz M, Cassel JB, Kaplan BJ, Karp SE, Neifeld JP, Penberthy LT, Bear HD.

J Surg Oncol. 2003 Oct;84(2):57-62.

PMID:
14502777
13.

Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.

Peterson DJ, Truong PT, Sadek BT, Alexander CS, Wiksyk B, Shenouda M, Raad RA, Taghian AG.

Ann Surg Oncol. 2014 Oct;21(11):3490-6. doi: 10.1245/s10434-014-3767-6. Epub 2014 May 20.

PMID:
24841346
14.

Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.

Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown M.

J Natl Cancer Inst. 2001 Mar 21;93(6):447-55.

PMID:
11259470
15.

Is mastectomy undertreatment for low-risk breast cancers eligible for breast-conserving therapy?

Bagaria SP, Wasif N, Rawal B, McLaughlin SA, Giuliano AE.

Cancer. 2015 Aug 15;121(16):2705-12. doi: 10.1002/cncr.29416. Epub 2015 Apr 28.

16.

Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?

Adkisson CD, Bagaria SP, Parker AS, Bray JM, Gibson T, Thomas CS, Heckman MG, McLaughlin SA.

Ann Surg Oncol. 2012 Apr;19(4):1129-36. doi: 10.1245/s10434-011-2080-x.

PMID:
21975859
17.

Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.

Pesce C, Liederbach E, Wang C, Lapin B, Winchester DJ, Yao K.

Ann Surg Oncol. 2014 Oct;21(10):3231-9. doi: 10.1245/s10434-014-3956-3. Epub 2014 Aug 1.

PMID:
25081341
18.

Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.

Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA.

Cancer. 2010 Sep 1;116(17):4000-6. doi: 10.1002/cncr.25197.

19.

Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years.

van der Sangen MJ, van de Wiel FM, Poortmans PM, Tjan-Heijnen VC, Nieuwenhuijzen GA, Roumen RM, Ernst MF, Tutein Nolthenius-Puylaert MC, Voogd AC.

Breast Cancer Res Treat. 2011 May;127(1):207-15. doi: 10.1007/s10549-010-1110-x. Epub 2010 Aug 12.

PMID:
20703938
20.

Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.

Levy A, Borget I, Bahri M, Arnedos M, Rivin E, Vielh P, Balleyguier C, Rimareix F, Bourgier C.

Breast J. 2014 Jul-Aug;20(4):381-7. doi: 10.1111/tbj.12277. Epub 2014 Jun 2.

PMID:
24890310

Supplemental Content

Support Center